Remdesivir Expanded Access
Note: This trial is no longer recruiting new patients.
Objective
Due to the lack of proven treatment options for COVID-19, the only medical intervention currently available to patients who develop severe or life-threatening illness is supportive care. Developing and researching potential treatments in an expedited fashion is a priority in combating this disease. Remdesivir is an investigational medication that has been approved by the FDA for compassionate use in patients with COVID-19 who have developed severe or life-threatening illness. Remdesivir is an antiviral medication that is designed to prevent proliferation of the virus within the body. It has been tested in hundreds of patients with SARS-CoV-2, the virus that causes COVID-19, and preliminary results suggest that the medication may improve clinical outcomes and prevent further disease progression.
Sponsor
Principal Investigator
Contact
Location
Overlake Medical Center
1035 116th Ave NE
Bellevue, WA 98004
Phone: (425) 688-5000
Resources
- ClinicalTrials.gov: Use NCT04323761 as the identifier to view a full description of this study.